Tumor cells, such as ovarian cancer cells and melanoma cells, release pro-angiogenic factors including ET-1 and VEGF that induce a pro-angiogenic phenotype in endothelial cells (EC) [56–59]. This evidence concerns the gene EDN1 and ovarian cancer.